27 – 29 February 2020
Dubai World Trade Centre
MB, BS (Hons), MD, DSc (hon), FACP, FICP, FRCP
President-Elect, International Diabetes Federation (IDF)
Past-President, European Association for the Study of Diabetes
President, Worldwide Initiative for Diabetes Education.
Professor Boulton is a graduate of Newcastle-upon-Tyne and subsequently trained in Sheffield, and Miami prior to accepting an appointment at Manchester University. He has authored more than 500 peer-reviewed manuscripts and book chapters, mainly on diabetic lower limb and renal complications.
Among his many awards, he has received the ADA’s Roger Pecoraro Lectureship, the EASD Camillo Golgi prize and was the first recipient of the international award on diabetic foot research. He was the 2008 winner of the ADA’s Harold Rifkin award for distinguished international service in diabetes. He received the 2012 Georgetown distinguished achievement award in diabetic limb salvage. In 2015 he visited Nagoya, Japan and gave a prize lecture on diabetic complications at the Japan Society of Diabetes, and in 2017 was the Banting Memorial Lecturer at Diabetes UK and also received the International Diabetes Endocrinologist Award of the year from the American Association of Clinical Endocrinologists.
A previous editor of Diabetic Medicine he is currently the senior associate editor of Diabetes Care.
In 2019 he was ranked the number one UK diabetes researcher in the field of complications.
He was the founding Chairman of the Diabetic Foot Study Group and was previously Chairman of Postgraduate Education and then Hon. Secretary/ programme chair for the EASD. Until late 2015 he was President of the EASD. Currently, President of Worldwide Initiative for Diabetes Education, President, International Diabetes Federation, and Chairman of EURADIA (European Alliance for Diabetes Research).
Douglas Ross is a Professor of Medicine at Harvard Medical School and Co-Director of the Massachusetts General Hospital Thyroid Clinic. He received his medical degree from Harvard Medical School. He completed his residency in internal medicine and his fellowship in endocrinology at the Massachusetts General Hospital. He is Thyroid Section Editor of UpToDate, and is an Associate Editor of Thyroid. He served as a member (2011) and chair (2016) of the American Thyroid Association’s Hyperthyroidism Guidelines Task Force. He is a member of the National Thyroid Cancer Treatment Cooperative Study Group, where he focused on outcomes of patients with papillary microcarcinoma.
Director, ASH Comprehensive Hypertension Center
The University of Chicago Medicine
Former President for Medicine & Science, American Diabetes Association
Director of Diabetes Care Center, University of North Carolina
Past President, European Federation of Endocrine Societies
Professor of Endocrinology, Oxford University
Past President of Women in Endocrinology
Chief of Endocrinology, Denver VA
Professor of Pediatrics and Medicine
Chief Emeritus, Division of Endocrinology and Diabetes
Director, Center for Bone Health
The Children’s Hospital of Philadelphia
Professor of Medicine, Division of Endocrinology, Metabolism and Diabetes, University of Colorado
Staff Physician and Investigator at VA Eastern Colorado Health Care System.
Director of CU Diabetes & Endocrinology Clinical Trials (DECT) Program
Professor of Clinical Pharmacy, University of Colorado Skaggs School of Pharmacy
Medical Director, Obesity Clinical Program,
Director of Inpatient Diabetes Program,
Joslin Diabetes Center,
Associate Professor of Medicine,
Harvard Medical School
Professor of Cardiomyopathies, Head of Laboratory for Heart Failure Research (www.hfresearch.eu), Maastricht University.
Professor of Matrix Biology, Department of Cardiovascular Science, Leuven University.
Chair Basic Science Section, Board Member of the European Heart Failure (HFA) Association of the ESC.
Former President, Georgia Regents University (GRU),
Chief Officer of Academic Health and Hospital Affairs
Past President of International Society for Pediatric and Adolescent Diabetes (ISPAD)
Professor of Paediatrics, Children’s Hospital ‘Auf der Bult’, Hannover
BSc (Hons) Ad Dip PGCE PhD RD
Chief Executive and Consultant Research Dietitian
Dr. Trudi Deakin is the chief executive of a charity specialising in research, training and structured education in the prevention and managemensuch as diabetes and obesity. She obtained a degree in nutrition and dietetics in 1993, a post graduate teaching qualification (PGCE) in 1998 and a doctorate in diabetes in 2004.
As founder of X-PERT Health and author of the X-PERT Programmes, She has trained more than 1,500 healthcare professionals to become educators, which has permitted the delivery of structured education to more than 300,000 people with prediabetes or diabetes. The clinical trial published in 2006 demonstrated that the X-PERT Programme significantly improves both health and quality of life along with a reduced requirement for medication. They perform annual audits and benchmark the results to the outcomes from the clinical trial to ensure that health improvement is still being achieved. They have partnered with one of the providers of the National Diabetes Prevention Programme in the UK and are proud that many more people will receive up-to-date and evidence based information to help them prevent Type 2 diabetes.
In 2017 they re-launched the X-PERT Insulin programme under the strapline of “reduce or omit”, which recognises that lifestyle changes can reduce requirement for insulin in Type 1 and Type 2 diabetes. More recently in January 2018 they launched the X-PERT Weight programme that provides people with the tools they need to achieve sustainable weight loss. Currently they are developing the digital programme that will be launched in January 2020. She is a visiting fellow at the University of Hertfordshire and a founding member of the Public Health Collaboration. These additional positions enable me to further develop professional and patient education systems that enable people to manage their long term condition, improving health and well-being, and saving healthcare costs.
Emirates Diabetes & Endocrine Congress (EDEC) is organized by Emirates Diabetes Society. EDEC is the region's premier platform to update attendees on the recent advances in the ever-changing field of diabetes and endocrine diseases.
|MCI Middle East |
United Arab Emirates
Tel: +971 4 311 6300
Fax: +971 4 311 6301